Analytical Data
-
Gene name
PX19
- Application
-
Alternative Names
25 kDa protein of relevant evolutionary and lymphoid interest;Px19-like protein
-
Species
Human
-
Source
E. coli
-
Tag
His tag N-Terminus
-
Purity
Greater than 90% as determined by SDS-PAGE.
-
Uniprot
Q9Y255
-
Expression Region
36-219 aa
-
AA Sequence
TEDIVHREVTPDQKLLSRRLLTKTNRMPRWAERLFPANVAHSVYVLEDSIVDPQNQTMTTFTWNINHARLMVVEERCVYCVNSDNSGWTEIRREAWVSSSLFGVSRAVQEFGLARFKSNVTKTMKGFEYILAKLQGEAPSKTLVETAKEAKEKAKETALAATEKAKDLASKAATKKQQQQQQFV
-
Molecular Weight
28.4 kDa
-
Endotoxin
< 1.0 EU per μg protein as determined by the LAL method.
-
Form
Freeze-dried powder
-
Buffer formulation
PBS, pH7.4, containing 0.01% SKL, 1mM DTT, 5% Trehalose and Proclin300.
-
Reconstitution
Reconstitute in ddH2O to a concentration of 0.1-0.5 mg/mL. Do not vortex.
- Customization
-
Stability Test
The thermal stability is described by the loss rate. The loss rate was determined by accelerated thermal degradation test, that is, incubate the protein at 37℃ for 48h, and no obvious degradation and precipitation were observed. The loss rate isless than 8% within the expiration date under appropriate storage condition.
-
Storage & Shelf Life
Samples are stable for up to twelve months from date of receipt at -20℃ to -80℃. Store it under sterile conditions at -20℃ to -80℃. It is recommended that the protein be aliquoted for optimal storage. Avoid repeated freeze-thaw cycles.
-
Shipping
In general, recombinant proteins are supplied as lyophilized powder and shipped at ambient temperature. For bulk packages, the proteins are provided as frozen liquid and shipped with blue ice, unless otherwise requested by the customer.
Quality inspection process
Related Products
Protein Description
PX19 recombinant protein is a subject of growing interest in the fields of molecular biology and therapeutic research due to its potential applications in various diseases, including cancer and autoimmune disorders. PX19, a product of genetic engineering, is derived from the interaction of certain protein domains involved in cellular signaling and immune responses. The protein’s unique structure allows it to modulate biological pathways, making it a candidate for targeted therapies. Previous studies highlighted the role of PX19 in regulating apoptosis and immune evasion in tumors, suggesting that it could be utilized for developing novel treatment strategies or as a biomarker for disease progression. Additionally, the recombinant production of PX19 enables large-scale synthesis, ensuring a consistent supply for extensive research and clinical applications. As researchers delve deeper into its mechanisms of action and interactions with cellular components, PX19 continues to be a focal point for understanding and potentially manipulating immune responses, thus paving the way for innovative therapeutic developments in precision medicine.
